Markets
Eli Lilly’s Diversification Offers Stronger Investment Case
Beyond its weight-loss drug success, Eli Lilly's robust pipeline across oncology, immunology, and neuroscience presents a compelling investment thesis.
#Investment 22 articles
Stocks
UnitedHealth Bets $1.5B on AI for 2x Return
UnitedHealth Group is investing $1.5 billion in AI for 2026, aiming for a conservative 2-to-1 return by streamlining claims, authorizations, and member...
Finance
Consumer Debt Attracts $150 Billion Private Credit Influx
Private credit firms have significantly increased their consumer debt holdings by $150 billion since 2019, reaching $350 billion, as they pursue high-yield...
Markets
Silver’s Triple-Digit Rally Fuels Top 5 Canadian Miners in Q1 2026
Silver's unprecedented rally to US$121.62 per ounce in early 2026 has significantly boosted Canadian silver miners. Five companies have emerged with the...